Mitochondrial and lysosomal signaling orchestrates heterogeneous metabolic states of regulatory T cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Resetting immunometabolic set points in autoimmune disease.Journal of translational autoimmunity · 2026
   Review
2. Metabolic exhaustion and immune ageing in rheumatoid arthritis.Nature reviews. Rheumatology · 2026
   Review
3. Spatial architecture of immunometabolism: Mitochondrial‑organelle interfaces in immune signaling (Review).International journal of molecular medicine · 2026
   Review
4. Reconsidering the Complex Role of Inflammation in Sudden Infant Death Syndrome.Cureus · 2026
   Review
5. Metabolic reprogramming of Th17/Treg imbalance in autoimmune thyroid diseases.Cell communication and signaling : CCS · 2026
   Review
6. Metabolic adaptation in CD4Nature immunology · 2026
   Article
7. Lysosomal dysfunction in diabetes and diabetic complications.Frontiers in endocrinology · 2026
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

21 authors.

Funding

Abstract

Indexed as